May 4, 2010Anavex Reports Animal Study Results as Lead Alzheimer’s Compound Approaches Phase 1 Clinical Trials
Sep 30, 2009Anavex Contracts FORENAP Pharma for Pre-Clinical Trials of ANAVEX 2-73 in Alzheimer's Disease
Jun 16, 2009ANAVEX Appoints Dr. Hervé de Kegrohen as CEO to Lead Company Through Clinical Trials & Future Growth
Feb 10, 2009Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board